How mRNA modifications can influence aging and protein expression
Translational regulation by covalent modification of mRNA
This study is looking at how changes to messenger RNA can influence how our bodies make proteins as we age, with the goal of finding new ways to promote longer, healthier lives using small molecules to boost protein activity.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10789242 on NIH RePORTER |
What this research studies
This research investigates how covalent modifications of messenger RNA (mRNA) can regulate protein expression, particularly in the context of aging. By exploring the mechanisms that affect cellular functions and intercellular communication, the study aims to identify ways to enhance longevity and healthspan. The approach involves using small molecules to increase protein activity and modulate gene expression, which could lead to breakthroughs in anti-aging therapies. The research will utilize cellular systems and mouse models to understand these processes better.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals interested in anti-aging treatments or those affected by age-related diseases.
Not a fit: Patients with acute conditions unrelated to aging or cellular function may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that promote healthier aging and potentially extend lifespan.
How similar studies have performed: While the specific approach of covalent mRNA modification is novel, similar research in RNA-targeted therapeutics has shown promising results.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Weeks, Kevin M — Univ of North Carolina Chapel Hill
- Study coordinator: Weeks, Kevin M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.